These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 11126385

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
    Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, Brown JJ, McFarland EG, Middleton WD, Balfe DM, Ritter JH.
    Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
    [Abstract] [Full Text] [Related]

  • 3. [Value of CT and MRI in malignant hepatobiliary tumors].
    Kahn T.
    Zentralbl Chir; 2000 Feb; 125(7):610-5. PubMed ID: 10960971
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
    De Gaetano AM, Rufini V, Castaldi P, Gatto AM, Filograna L, Giordano A, Bonomo L.
    Abdom Imaging; 2012 Dec; 37(6):983-1003. PubMed ID: 22527152
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Dec; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The use of imaging in the diagnosis and staging of hepatobiliary malignancies.
    Miller G, Schwartz LH, D'Angelica M.
    Surg Oncol Clin N Am; 2007 Apr; 16(2):343-68. PubMed ID: 17560517
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
    Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM.
    AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium.
    Hori M, Murakami T, Oi H, Kim T, Takahashi S, Matsushita M, Tomoda K, Narumi Y, Kadowaki K, Nakamura H.
    Acta Radiol; 1998 Mar; 39(2):144-51. PubMed ID: 9529444
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of coexistent hepatic tumors of different kinds: a challenge from CT and MR imaging.
    Itai Y, Ohtomo K, Kokubo T, Yoshida H, Minami M, Kawauchi N, Okada Y.
    Radiat Med; 1989 Mar; 7(3):143-9. PubMed ID: 2555846
    [Abstract] [Full Text] [Related]

  • 20. [Imaging diagnosis of hepatocellular carcinomas].
    Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Arai K, Gabata T, Takashima T, Ida M, Miyata S.
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):25-33. PubMed ID: 2536268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.